ArticleMolecular therapy. Methods & clinical development2023

A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.

Stephen Boulton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.